sitravatinib   Click here for help

GtoPdb Ligand ID: 9920

Synonyms: GCD-516 | GCD516 | MGCD516
Compound class: Synthetic organic
Comment: Sitravatinib (MGCD516) is an inhibitor of multiple receptor tyrosine kinases (RTKs) that was developed as an antineoplatic agent [1]. It targets several RTKs (e.g. c-Met, PDGFR, c-Kit and IGF1-R) whose overexpression has been shown to drive sarcoma cell growth
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 14
Topological polar surface area 142.71
Molecular weight 629.19
XLogP 4.41
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES COCCNCc1ccc(nc1)c1sc2c(c1)nccc2Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
Isomeric SMILES COCCNCc1ccc(nc1)c1sc2c(c1)nccc2Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
InChI InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)
InChI Key WLAVZAAODLTUSW-UHFFFAOYSA-N
Bioactivity Comments
Sitravatinib is reported to produce superior antiproliferative efficacy than imatinib and crizotinib in vitro and in vivo [1].
A selection of the inhibitory IC50s reported in [1] (Table 1) are included in our table below. In some cases we have restricted our selection to the most potently inhibited isoform from each subfamily of RTKs that were tested.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
discoidin domain receptor tyrosine kinase 2 Hs Inhibitor Inhibition 9.3 pIC50 - 1
⤷ pIC50 9.3 (IC50 5x10-10 M) [1]
Description: In a biochemical enzyme activity assay.
EPH receptor A3 Hs Inhibitor Inhibition 9.0 pIC50 - 1
⤷ pIC50 9.0 (IC50 1x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
AXL receptor tyrosine kinase Hs Inhibitor Inhibition 8.8 pIC50 - 1
⤷ pIC50 8.8 (IC50 1.5x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
fms related receptor tyrosine kinase 4 Hs Inhibitor Inhibition 8.7 pIC50 - 1
⤷ pIC50 8.7 (IC50 2x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
MER proto-oncogene, tyrosine kinase Hs Inhibitor Inhibition 8.7 pIC50 - 1
⤷ pIC50 8.7 (IC50 2x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
kinase insert domain receptor Hs Inhibitor Inhibition 8.3 pIC50 - 1
⤷ pIC50 8.3 (IC50 5x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
neurotrophic receptor tyrosine kinase 1 Hs Inhibitor Inhibition 8.3 pIC50 - 1
⤷ pIC50 8.3 (IC50 5x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
KIT proto-oncogene, receptor tyrosine kinase Hs Inhibitor Inhibition 8.2 pIC50 - 1
⤷ pIC50 8.2 (IC50 6x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
fms related receptor tyrosine kinase 1 Hs Inhibitor Inhibition 8.2 pIC50 - 1
⤷ pIC50 8.2 (IC50 6x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
fms related receptor tyrosine kinase 3 Hs Inhibitor Inhibition 8.1 pIC50 - 1
⤷ pIC50 8.1 (IC50 8x10-9 M) [1]
Description: In a biochemical enzyme activity assay.
MET proto-oncogene, receptor tyrosine kinase Hs Inhibitor Inhibition 7.7 pIC50 - 1
⤷ pIC50 7.7 (IC50 2x10-8 M) [1]
Description: In a biochemical enzyme activity assay.
platelet derived growth factor receptor alpha Hs Inhibitor Inhibition 7.5 pIC50 - 1
⤷ pIC50 7.5 (IC50 3x10-8 M) [1]
Description: In a biochemical enzyme activity assay.